NCT06278870 2024-02-26Disitamab Vedotin + Pyrotinib Versus THP in the First-line Treatment for HER2+ Advanced Breast Cancer Clinical TrialSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityPhase 3 Recruiting312 enrolled
NCT04646759 2020-11-30Fulvestrant or Capecitabine Combined With Pyrotinib in HR+/HER2+ Metastatic Breast CancerSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityPhase 3 Recruiting516 enrolled